KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Other Non-Current Liabilities: 2013-2023

Historic Other Non-Current Liabilities for Palvella Therapeutics (PVLA) over the last 5 years, with Dec 2023 value amounting to $1.0 million.

  • Palvella Therapeutics' Other Non-Current Liabilities was N/A to $1.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2023, which is N/A change from last year.
  • As of Q4 2023, Palvella Therapeutics' Other Non-Current Liabilities stood at $1.0 million, which was up 16,800.00% from $6,000 recorded in Q4 2020.
  • Palvella Therapeutics' 5-year Other Non-Current Liabilities high stood at $12.3 million for Q2 2019, and its period low was $6,000 during Q4 2020.
  • Moreover, its 1-year median value for Other Non-Current Liabilities was $1.0 million (2023), whereas its average is $1.0 million.
  • Within the past 5 years, the most significant YoY rise in Palvella Therapeutics' Other Non-Current Liabilities was 37,656.25% (2019), while the steepest drop was 27.03% (2019).
  • Over the past 3 years, Palvella Therapeutics' Other Non-Current Liabilities (Quarterly) stood at $12.1 million in 2019, then followed by $6,000 in 2020, then followed by $1.0 million in 2023.
  • Its Other Non-Current Liabilities was $1.0 million in Q4 2023, compared to $6,000 in Q4 2020 and $12.1 million in Q3 2019.